AN2 Therapeutics plans sale of 1.0M ANTX shares

ANTX filed a notice indicating an intention to sell common stock.

Rhea-AI Filing Summary

ANTX filed a notice indicating an intention to sell common stock. The filing lists 1,012,000 shares of common stock associated with a value of $6,080,268.00, alongside another share figure of 37,736,237, in connection with the issuer’s Nasdaq-listed stock. The proposed sales relate to shares previously acquired from the issuer on several dates between 2019 and 2022.

Key Figures

Shares proposed for sale: 1,012,000 shares Associated value: $6,080,268.00 Additional share figure: 37,736,237 +5 more

8 metrics

Shares proposed for sale 1,012,000 shares Common stock entry associated with Stifel Nicolaus & Company Inc

Associated value $6,080,268.00 Value listed on the same line as 1,012,000 common shares

Additional share figure 37,736,237 Number listed with the common stock sale data

Prior acquisition 1 577,700 shares Owned shares of common stock dated 11/19/2019 from issuer

Prior acquisition 2 185,497 shares Owned shares of common stock dated 10/05/2020 from issuer

Prior acquisition 3 133,230 shares Owned shares of common stock dated 03/05/2021 from issuer

Prior acquisition 4 153,334 shares Owned shares of common stock dated 03/25/2022 from issuer

Sale period related date 08/17/2026 Date listed with the common stock sale line item

Key Terms

Securities To Be Sold, Owned Shares, Nasdaq

3 terms

Securities To Be Sold financial

"144: Securities To Be Sold Common Stock | 11/19/2019 | Owned Shares"

Owned Shares financial

"Common Stock | 11/19/2019 | Owned Shares | Issuer"

Nasdaq market

"37736237 | 08/17/2026 | Nasdaq"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ANTX disclose in this Form 144 filing?

ANTX discloses an intention to sell 1,012,000 shares of its common stock. The notice also lists an associated value of $6,080,268.00 and another share figure of 37,736,237 related to the issuer’s Nasdaq-listed securities.

How many ANTX shares are proposed to be sold under this Form 144?

The Form 144 indicates a proposed sale of 1,012,000 shares of ANTX common stock. These shares are connected to prior acquisitions from the issuer on several dates between 2019 and 2022, as detailed in the ownership history section.

What dollar value is associated with the ANTX shares in this Form 144?

The filing associates the ANTX common stock with a value of $6,080,268.00. This figure appears in the same line as the 1,012,000 shares of common stock and other related data, including a Nasdaq reference.

What other share figure is listed in ANTX’s Form 144 besides the shares to be sold?

Alongside the 1,012,000 shares proposed for sale, the Form 144 lists another share figure of 37,736,237. This number appears in the same data line as the sale information for ANTX common stock on Nasdaq.

What is the acquisition history of the ANTX shares referenced in this Form 144?

The notice shows prior acquisitions of ANTX common stock as 577,700 shares on 11/19/2019, 185,497 on 10/05/2020, 133,230 on 03/05/2021, and 153,334 on 03/25/2022, all labeled as owned shares from the issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/17/2026 - 04:24 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001914883
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AN2 Therapeutics, Inc.
SEC File Number	001-41331
Address of Issuer	1300 EL CAMINO REAL, SUITE 100 MENLO PARK CALIFORNIA 94025
Phone	(650) 331-9090
Name of Person for Whose Account the Securities are To Be Sold	Readnour Robin Shane
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	1012000	6080268.00	37736237	08/17/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	11/19/2019	Owned Shares	Issuer			577700	11/19/2019	Owned Shares
Common Stock	10/05/2020	Owned Shares	Issuer			185497	10/05/2020	Owned Shares
Common Stock	03/05/2021	Owned Shares	Issuer			133230	03/05/2021	Owned Shares
Common Stock	03/25/2022	Owned Shares	Issuer			153334	03/25/2022	Owned Shares

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Shares sold under MGC Venture Partners 2018, LP and MGC Venture Partners QP 2018, LP pursuant to their respective 10b5-1 plan
Date of Notice	08/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	04/23/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Azad Daswani, as a duly authorized representative of STIFEL, as attorney-in-fact for Robin Readnor
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)